June 02, 2016 - In patients with metastatic colorectal cancer, the location in the colon where the tumor originated appears to strongly influence how long patients live, according to a new study.
The studyExit Disclaimer—a retrospective analysis of data from a large NCI-funded phase III clinical trial—found that patients whose cancer originated in the left side of the colon (distal colon) lived more than a year longer after initial treatment than patients whose disease originated in the right side of the colon (proximal colon). Read more here.
No comments:
Post a Comment